Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anti-VEGF compounds in the treatment of neovascular age related macular degeneration.
Campa C, Harding SP. Campa C, et al. Among authors: harding sp. Curr Drug Targets. 2011 Feb;12(2):173-81. doi: 10.2174/138945011794182674. Curr Drug Targets. 2011. PMID: 20887245 Review.
Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'.
Barnes RM, Gee L, Taylor S, Briggs MC, Harding SP. Barnes RM, et al. Among authors: harding sp. Eye (Lond). 2004 Aug;18(8):809-13. doi: 10.1038/sj.eye.6701329. Eye (Lond). 2004. PMID: 14963483
Diabetic retinopathy.
Harding S. Harding S. Clin Evid. 2003 Jun;(9):718-28. Clin Evid. 2003. PMID: 15366162 Updated. Review. No abstract available.
Optical coherence tomography analysis of bilateral end-stage choroidal neovascularization where one eye is treated with photodynamic therapy.
Sahni J, Stanga P, Wong D, Lenfestey P, Kent D, Harding S. Sahni J, et al. Clin Exp Ophthalmol. 2007 Jan-Feb;35(1):13-7. doi: 10.1111/j.1442-9071.2006.01385.x. Clin Exp Ophthalmol. 2007. PMID: 17300565
Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy.
Mackay AM, Brown MC, Hagan RP, Fisher AC, Grierson I, Harding SP. Mackay AM, et al. Among authors: harding sp. Doc Ophthalmol. 2007 Sep;115(2):69-76. doi: 10.1007/s10633-007-9056-y. Epub 2007 Aug 2. Doc Ophthalmol. 2007. PMID: 17671804
Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration.
Mackay AM, Brown MC, Grierson I, Harding SP. Mackay AM, et al. Among authors: harding sp. Doc Ophthalmol. 2008 Jan;116(1):13-8. doi: 10.1007/s10633-007-9071-z. Epub 2007 Sep 21. Doc Ophthalmol. 2008. PMID: 17885777
Early response of retinal angiomatous proliferation treated with intravitreal pegaptanib: a retrospective review.
Mahmood S, Kumar N, Lenfestey PM, Murjaneh S, Heimann H, Harding SP. Mahmood S, et al. Among authors: harding sp. Eye (Lond). 2009 Mar;23(3):530-5. doi: 10.1038/eye.2008.101. Epub 2008 Apr 18. Eye (Lond). 2009. PMID: 18425070
Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration.
Murjaneh S, García-Fiñana M, Mahmood S, Lenfestey PM, Taylor SA, Pearce IA, Briggs MC, Heimann H, Harding SP. Murjaneh S, et al. Among authors: harding sp. Br J Ophthalmol. 2009 Apr;93(4):468-73. doi: 10.1136/bjo.2008.141366. Epub 2008 Dec 15. Br J Ophthalmol. 2009. PMID: 19074914 Clinical Trial.
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes.
Harding SP, Tomlin K, Reeves BC, Langham J, Walker J, Carpenter J, Grieve R, Patton WP, Muldrew KA, Peto T, Chakravarthy U; Verteporfin Photodynamic Therapy Cohort Study Group. Harding SP, et al. Ophthalmology. 2009 Dec;116(12):e1-8. doi: 10.1016/j.ophtha.2009.10.022. Ophthalmology. 2009. PMID: 19948275 Clinical Trial.
Neovascular age-related macular degeneration: decision making and optimal management.
Harding SP. Harding SP. Eye (Lond). 2010 Mar;24(3):497-505. doi: 10.1038/eye.2009.316. Epub 2010 Jan 8. Eye (Lond). 2010. PMID: 20057511 Review.
158 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page